– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
Monoclonal antibodies, the drug cocktail used to treat patients infected with COVID-19, have proven to be an invaluable tool to limit severe disease and hospitalizations since the U.S. Food and Drug ...
When Bea Amma visited a med spa in 2021, she was hoping for treatments that would boost her energy and help burn off some body fat. She never imagined she would end up with a drug-resistant infection ...
Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous infusion, according to study ...
Alexandria, VA, May 28, 2024 (GLOBE NEWSWIRE) -- Drip Docx, a leading concierge medical spa, is excited to highlight its innovative IV therapy treatments, advanced laser hair removal services, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results